Researchers in Korea have determined the possibility that adult mesenchymal stem cells (MSCs) may extend healthy life and lifespan by intravenous injections.
Professor Kim from Chungbuk National University and Dr. Ra from Biostar, as a joint research team, announced that the discovery was published in International Journal of Medicine, 'Stem Cells Translation Medicine' (IF 5.7) on August 27, 2015.
The study, which is selected as the featured paper, intends to introduce the research to the public. As a result of monthly intravenous injections of 1 million human adipose-derived stem cells into 10-month old rats until their death, cognitive function such as learning and memory improved and lifespan was extended by 31.3% through regeneration of blood vessels in the brain and muscles.
The Future of Using Adult Mesenchymal Stem Cells To Extend Life
Dr. Ra told The Biotechnician that this is just the beginning. " Study for prevention of degenerative disease and cancer through identifying mechanisms of physiological Homeostasis. When commercialized stem cell technology and development is to increase healthy lifespan, young people intend to bank their own stem cells and receive them regularly from the age of 60s," said Dr. Ra.
In order to continue to make progress, his team will continue to study Alzheimer's disease and MCI to figure out how to improve cognitive abilities and memory with stem cell treatments. In order to keep doing going and take this to the public, Dr. Ra believes that it will first start off in Japan before moving to other areas.
" Stem cell treatments for anti-aging and the prevention of Alzheimer's disease will start in Japan. We would like to operate the global stem cell bank with pioneer stem cell researchers in the world based on our developing stem cell technology and the experience in Korea," said Ra.